This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Stephen A. Feig, MD

JAMA. 1996;276(1):73-74.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Reduction of mortality due to breast cancer among women aged 40 to 49 years represents a major challenge and opportunity for mammographic screening. The American Cancer Society estimates that in 1995 alone, some 33 800 women aged 40 to 49 years were diagnosed with breast cancer. This is 19% greater than the number of women who were diagnosed between the ages of 50 and 59 years (28 300) and 18% fewer than the number of women diagnosed between the ages of 60 and 69 years (41300).¹ It has been estimated that almost 20% of all deaths due to breast cancer and 34% of all the expected years of life lost due to breast cancer result from breast cancers found among women aged 40 to 49 years.²

See also pp 33 and 39.

Proof of benefit from screening women in any age group can come only from a randomized . . . [Full Text PDF of this Article]

Author Affiliations
From the Breast Imaging Center, Department of Radiology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pa.

Footnotes
Reprints: Stephen A. Feig, MD, Breast Imaging Center, Thomas Jefferson University Hospital, 1100 Walnut St, Philadelphia, PA 19107-5563.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?